Key result
A single dose of the E. coli-produced FMDV VLP subunit vaccine elicited strong protective immunity in cattle, achieving a high protection potency of 11.75 PD50 per dose against FMDV Asia1 challenge.
Authors
Loading...
May enable scalable FMDV VLP production; leaves open veterinary vaccine translation and efficacy.
Effect estimate: 11.75 PD50 per dose
Xiao et al. (2016) studied Foot-and-mouth disease (FMDV serotype Asia1) (n=27). FMDV VLP subunit vaccine (serotype Asia1) vs. PBS (sham-vaccinated) was evaluated on 50% bovine protective dose (PD50) against FMDV challenge (11.75 PD50 per dose). A single dose of the E. coli-produced FMDV VLP subunit vaccine elicited strong protective immunity in cattle, achieving a high protection potency of 11.75 PD50 per dose against FMDV Asia1 challenge.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: